Ani Pharmaceuticals ANIP
NASDAQ ANIP
$72.18 -0.78 (-1.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ani Pharmaceuticals (ANIP) Other Accumulated Expenses (2010 - 2026)

Updated

Ani Pharmaceuticals' Other Accumulated Expenses came in at $55.83 million for Q2 2026, up 55.0% from $36.03 million a year earlier and up 64.6% from the prior quarter.

Analysis

Ani Pharmaceuticals (ANIP) Other Accumulated Expenses (2010 - 2026) Analysis & Trends

At the end of FY2025, Ani Pharmaceuticals' Other Accumulated Expenses was $48.5 million, up 114.3% from FY2024.

  • Other Accumulated Expenses has increased in each of the last four years, with a five-year compound annual growth rate of 49.9% (FY2020 to FY2025).
  • Going back by year, Other Accumulated Expenses was $22.63 million in FY2024 (+39.0%), $16.28 million in FY2023 (+74.9%), $9.31 million in FY2022 (+49.5%) and $6.23 million in FY2021 (-2.8%).
  • The Q2 2026 figure represents the highest quarterly Other Accumulated Expenses in data going back to Q4 2010.
  • Year-over-year, Other Accumulated Expenses has increased for 17 consecutive quarters, with growth averaging 74.5% over the last eight quarters.
  • The fastest year-over-year change in Other Accumulated Expenses over five years came in Q3 2025 (growth of 118.6%), and the weakest in Q3 2021 (a decline of 34.4%).
  • Business Quant data shows ANIP's Other Accumulated Expenses at $33.93 million (Q1 2026), $48.5 million (Q4 2025) and $51.25 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Ani Pharmaceuticals 1.72 Bn 502.13 Mn 165.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 55.83 Mn
Mar 31, 2026 33.93 Mn
Dec 31, 2025 48.50 Mn
Sep 30, 2025 51.25 Mn
Jun 30, 2025 36.03 Mn
Mar 31, 2025 23.71 Mn
Dec 31, 2024 22.63 Mn
Sep 30, 2024 23.45 Mn
Jun 30, 2024 20.36 Mn
Mar 31, 2024 15.48 Mn
Dec 31, 2023 16.28 Mn
Sep 30, 2023 11.98 Mn
Jun 30, 2023 9.89 Mn
Mar 31, 2023 8.96 Mn
Dec 31, 2022 9.31 Mn
Sep 30, 2022 6.59 Mn
Jun 30, 2022 6.30 Mn
Mar 31, 2022 5.00 Mn
Dec 31, 2021 6.23 Mn
Sep 30, 2021 4.00 Mn
API Access

Ani Pharmaceuticals Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ANIP&period=max&api_key=YOUR_API_KEY